Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 May;78(5):402–403. doi: 10.1136/adc.78.5.402

Licensing of medicines

I CHOONARA 1, J DUNNE 1
PMCID: PMC1717564  PMID: 9659082

Full Text

The Full Text of this article is available as a PDF (59.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aranda J. V., Stern L. Clinical aspects of developmental pharmacology and toxicology. Pharmacol Ther. 1983;20(1):1–51. doi: 10.1016/0163-7258(83)90044-x. [DOI] [PubMed] [Google Scholar]
  2. Benini F., Johnston C. C., Faucher D., Aranda J. V. Topical anesthesia during circumcision in newborn infants. JAMA. 1993 Aug 18;270(7):850–853. [PubMed] [Google Scholar]
  3. Cornelissen E. A., Kollée L. A., De Abreu R. A., van Baal J. M., Motohara K., Verbruggen B., Monnens L. A. Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child. 1992 Oct;67(10):1250–1254. doi: 10.1136/adc.67.10.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dreifuss F. E., Santilli N., Langer D. H., Sweeney K. P., Moline K. A., Menander K. B. Valproic acid hepatic fatalities: a retrospective review. Neurology. 1987 Mar;37(3):379–385. doi: 10.1212/wnl.37.3.379. [DOI] [PubMed] [Google Scholar]
  5. Fisher E., Siemes H., Pund R., Wittfoht W., Nau H. Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia. 1992 Jan-Feb;33(1):165–171. doi: 10.1111/j.1528-1157.1992.tb02301.x. [DOI] [PubMed] [Google Scholar]
  6. Kearns G. L., Reed M. D. Immediate action needed to improve labeling of prescription drugs for pediatric patients. Ann Pharmacother. 1997 Feb;31(2):249–251. doi: 10.1177/106002809703100220. [DOI] [PubMed] [Google Scholar]
  7. Linday L. A., Ehlers K. H., O'Loughlin J. E., LaGamma E. F., Engle M. A. Noninvasive diagnosis of persistent fetal circulation versus congenital cardiovascular defects. Am J Cardiol. 1983 Oct 1;52(7):847–851. doi: 10.1016/0002-9149(83)90426-5. [DOI] [PubMed] [Google Scholar]
  8. Parkinson L., Hughes J., Gill A., Billingham I., Ratcliffe J., Choonara I. A randomized controlled trial of sedation in the critically ill. Paediatr Anaesth. 1997;7(5):405–410. doi: 10.1046/j.1460-9592.1997.d01-109.x. [DOI] [PubMed] [Google Scholar]
  9. SUTHERLAND J. M. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child. 1959 Jun;97(6):761–767. doi: 10.1001/archpedi.1959.02070010763001. [DOI] [PubMed] [Google Scholar]
  10. Skinner J. R., Hunter S., Hey E. N. Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome. Arch Dis Child Fetal Neonatal Ed. 1996 Jan;74(1):F26–F32. doi: 10.1136/fn.74.1.f26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Starko K. M., Ray C. G., Dominguez L. B., Stromberg W. L., Woodall D. F. Reye's syndrome and salicylate use. Pediatrics. 1980 Dec;66(6):859–864. [PubMed] [Google Scholar]
  12. Turner S., Gill A., Nunn T., Hewitt B., Choonara I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet. 1996 Feb 24;347(9000):549–550. [PubMed] [Google Scholar]
  13. WEISS C. F., GLAZKO A. J., WESTON J. K. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med. 1960 Apr 21;262:787–794. doi: 10.1056/NEJM196004212621601. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES